Marshall Wace, LLP Axcella Health Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.06 - $3.61 $82,435 - $144,461	-40,017 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $96,566 - $139,665	-32,405 Reduced 44.74%	40,017 $119,000
Q2 2021 Aug 13, 2021	BUY	$3.08 - $5.13 $53,243 - $88,682	17,287 Added 31.35%	72,422 $290,000
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $23,532 - $34,755	-5,172 Reduced 8.58%	55,135 $262,000
Q3 2020 Nov 16, 2020	SELL	$4.12 - $5.91 $242,515 - $347,880	-58,863 Reduced 49.39%	60,307 $279,000
Q2 2020 Aug 13, 2020	BUY	$2.94 - $7.7 $350,359 - $917,609	119,170 New	119,170 $660,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.